13F Data
13F filer · CIK 1577524

Sarissa Capital Management LP

GREENWICH, CT · filing since Q4 2013 · last filing Aug 14, 2026
Reported value
$177.9M
+$20.2M vs prior
Positions
10
New / sold out
1 / 0
Added / reduced
1 / 1
Turnover
0.3%
buys $489.9K · sells $5.5M
Top-10 weight
100.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedBIOHAVEN LTD+19,128+3.4%+$284.6K
NewBIOGEN INC+950–+$205.3K

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedINNOVIVA INC-240,346-11.3%$-5.5M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2013: $267.0MQ1 2014: $290.4MQ2 2014: $294.1MQ3 2014: $258.9MQ4 2014: $282.5MQ1 2015: $474.1MQ2 2015: $434.6MQ3 2015: $404.9MQ4 2015: $514.4MQ1 2016: $453.8MQ2 2016: $352.3MQ3 2016: $434.2MQ4 2016: $363.1MQ1 2017: $253.1MQ2 2017: $299.6MQ3 2017: $324.0MQ4 2017: $390.6MQ1 2018: $432.1MQ2 2018: $498.8MQ3 2018: $453.3MQ4 2018: $451.2MQ1 2019: $664.3MQ2 2019: $802.2MQ3 2019: $797.9MQ4 2019: $1.2BQ1 2020: $783.8MQ2 2020: $898.9MQ3 2020: $849.4MQ4 2020: $979.8MQ1 2021: $1.0BQ2 2021: $1.3BQ3 2021: $1.3BQ4 2021: $1.2BQ1 2022: $1.1BQ2 2022: $993.5MQ3 2022: $884.8MQ4 2022: $840.2MQ1 2023: $781.9MQ2 2023: $1.0BQ3 2023: $742.4MQ4 2023: $648.9MQ1 2024: $571.6MQ2 2024: $592.4MQ3 2024: $402.3MQ4 2024: $322.9MQ1 2025: $154.7MQ2 2025: $154.4MQ3 2025: $180.4MQ4 2025: $222.9MQ1 2026: $157.6MQ2 2026: $177.9M
Q4 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1INNOVIVA INCCOM1,890,604$42.9M24.14%
2IRONWOOD PHARMACEUTICALS INCCOM CL A9,188,635$38.7M21.75%
3AMARIN CORP PLCSPONSORED ADR1,673,395$26.7M15.00%
4NEUROCRINE BIOSCIENCES INCCOM116,533$19.6M11.04%
5CYTOKINETICS INCCOM NEW228,623$19.5M10.95%
6LANTHEUS HLDGS INCCOM166,919$18.5M10.41%
7BIOHAVEN LTDCOM582,312$8.7M4.87%
8REGENERON PHARMACEUTICALSCOM4,190$2.6M1.47%
9VOR BIOPHARMA INCCOM NEW25,399$467.6K0.26%
10BIOGEN INCCOM950$205.3K0.12%